Ä¢¹½´«Ã½

Despite significant improvements in the quality and efficacy of hemodialysis therapy in recent years, cardiovascular disease (CVD) remains the leading cause of death for dialysis patients. Today, almost every other dialysis patient dies from cardiovascular complications1.

Ä¢¹½´«Ã½ supports nephrologists worldwide in minimizing their patientsÄ¢¹½´«Ã½™ risks for cardiovascular morbidity and mortality.
HighVolumeHDF therapy as well as innovative membranes like Helixoneplus and modern monitoring features like the Blood Volume Monitor, together with ultrapure dialysis fluid, help minimize CVD risk factors and significantly improve hemodialysis therapy.

Reference:
1. Mario Cozzolino et al. Cardiovascular disease in dialysis patients. Nephrol Dial Transplant. 2018 Oct; 33(Suppl 3): iii28Ä¢¹½´«Ã½“iii34

Dialysis essentially replicates the functions of the kidneys in patients with chronic kidney failure. Hemodialysis and Peritoneal Dialysis take over the critical tasks of the kidneys, removing waste materials, toxins, excess salt and fluids from the body.

Dialysis treatment does not entirely replace all the functions of the kidneys, meaning that patients almost always need to take certain medications regularly. These include antihypertensive treatments, drugs for lowering phosphate levels in the blood, vitamins and medicines that boost the production of red blood cells to prevent anemia.

Ä¢¹½´«Ã½ Seating has been designing and producing Australian made, world leading Medical Treatment Chairs for over 15 years. Ä¢¹½´«Ã½Ä¢¹½´«Ã½™s versatile range of Medical Treatment Chairs ensures that Australia's leading healthcare centres have the most advanced medical chairs available.

Our manufacturing facility is based in Melbourne, Australia. There we design and build all Ä¢¹½´«Ã½ Seating equipment. Our seating range is distributed nationally and internationally including the US, China, India, Canada, South East Asia and New Zealand.

Innovative Information Technology to assist Healthcare Professionals in caring for their dialysis patients.

The ability to capture obtain and analyse patient-related data is crucial for both dialysis treatment monitoring and planning. With this in mind, Ä¢¹½´«Ã½ has developed innovative information technology application to assist healthcare professionals in caring for their dialysis patients.

Peritoneal dialysis (PD) management software PatientOnLine has been developed for monitoring patients undergoing Peritoneal Dialysis while Therapy Data Management System (TDMS) has been developed to monitor those undergoing Haemodialysis.

Patients undergoing Haemodialysis are exposed to large volumes of water in the form of dialysis fluid. In fact, a person undergoing Haemodialysis may come into contact with more fluid than the average healthy person in their entire lifetime.1

As part of our commitment to supporting clinicians and their patients undergoing dialysis, Ä¢¹½´«Ã½ provides innovative water treatment products and services for dialysis therapy.

Reference:
1. Ward RA. Semin Nephrol 2005;25:102Ä¢¹½´«Ã½“11.

Fresenius Kidney Care, the dialysis care services division of Ä¢¹½´«Ã½, strives to set the standard in the healthcare industry by delivering care that demonstrates improvements in the quality of life for every patient every day.

We are known for our ability to successfully partner and work with physicians across the region. Our clinical care standards, safety procedures and advanced clinical research reassure physicians that their patients are in caring and competent hands.

With our performance management systems, we strive to improve patientsÄ¢¹½´«Ã½™ medical outcomes while optimizing operational performances of clinics, taking all dimensions of patient care into account.

Ä¢¹½´«Ã½ is highly committed to supporting the advancement of genuine medical/scientific education of healthcare professionals in relevant therapeutic areas, and therefore contributes to the improvement of healthcare standards and enhanced patient care.

Education and services to support your therapy programme.

Selected congresses, meetings, seminars and symposia

Supporting medical and scientific education of Healthcare Professionals.

Ä¢¹½´«Ã½ Ventures was established to invest in start-ups and early-stage companies in the healthcare sector.Ìý

Ä¢¹½´«Ã½ Australia and New Zealand provide a range of Procedure Packs to support renal therapy at clinics and for patients. The packs are manufactured locally in Australia.

Contact us for further information on our Packs.